Emicizumab Biosimilar (F9 / Factor IX Reference Antibody)
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research.
Product Specifications
Target
Emicizumab Biosimilar (Anti-F9 / Factor IX Reference Antibody)
Clonality
Recombinant
Conjugation
Unconjugated
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1683504 1.0 µg DNA
POLR2G sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
ARP47681_P050-FITC 100 µL
IRX1 Antibody - middle region : FITC (ARP47681_P050-FITC)
Sign In for Pricing
View Details 
MBS6405015-01 0.1 mL
ABCF2 (ATP-binding Cassette, Sub-family F, Member 2, ABC28, HUSSY18, HUSSY-18, EST133090) (Biotin)
Sign In for Pricing
View Details MBS6405015-02 5x 0.1 mL
ABCF2 (ATP-binding Cassette, Sub-family F, Member 2, ABC28, HUSSY18, HUSSY-18, EST133090) (Biotin)
Sign In for Pricing
View Details 